STERISHEALTHCARE Products
Mumbai info@sterispharma.com
918824175417
Chat with us  

Chat with us on WhatsApp

×
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
Home Products FOSFOZYME 3
FOSFOZYME 3Fosfomyc
FOSFOZYME 3Fosfomyc
COD not available
ORTHOLOGYRANG by Fosfomycin Trometamol Powder

FOSFOZYME 3

INR 227 INR 325
You Save: INR 98 (30.15%)
Check On
Share with
Check On
Share this on :

Description

Product details

FOSFOZYME 3 Fosfomycin Trometamol Powder "FOSFOZYME 3 contains Fosfomycin Trometamol, a potent antibiotic targeting urinary tract infections. Each sachet efficiently combats bacteria by inhibiting cell wall synthesis, offering quick relief. Ideal for single-dose administration, it ensures convenience and compliance in UTI treatment. Suitable for adults and available in powder form for oral solution." This description stays within the 200 character limit and highlights the key features and uses of the medication. For further information: Email: info@sterispharma.com / contact@sterispharma.com Call/WhatsApp: 7877551268, 7849827488 Order Now:

Keywords

Other Products

Related Products

ALFUGEM T 5/10 is a uniquely formulated combination of Alfuzosin Hydrochloride ER and Tadalafil, created to manage two common male health concerns—benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). This dual-benefit tablet not only helps relieve urinary symptoms caused by an enlarged prostate but also enhances sexual performance by improving blood flow to penile tissues. Alfuzosin, an alpha-1 adrenergic blocker, works by relaxing the smooth muscles of the prostate and bladder neck, allowing for easier urine flow. On the other hand, Tadalafil, a PDE5 inhibitor, relaxes blood vessels and supports better erections during sexual activity. Together, they offer a holistic treatment option for men dealing with both prostate-related urinary difficulties and sexual health concerns. Uses of ALFUGEM T 5/10 Benign Prostatic Hyperplasia (BPH): Eases urinary issues such as weak stream, frequent urination, incomplete bladder emptying, and difficulty initiating urination. Erectile Dysfunction (ED): Improves erectile quality and sexual satisfaction. Dual Therapy: Provides relief for men suffering from both BPH and ED, minimizing the need for multiple medications. Enhanced Quality of Life: Restores comfort, confidence, and overall wellness by improving both urinary and sexual functions. Side Effects of ALFUGEM T 5/10 Like most medications, ALFUGEM T 5/10 may cause side effects, usually mild and temporary as the body adapts to treatment. Common side effects include: Headache Dizziness or lightheadedness Nasal congestion Back pain Flushing Less common but serious side effects: Sudden low blood pressure (hypotension) Severe dizziness or fainting Prolonged, painful erections (priapism – requires urgent care) Vision or hearing disturbances Allergic reactions (rash, itching, facial/lip/throat swelling) Precautions Before Use Heart Problems: Patients with recent heart attack, stroke, or serious heart disease should only use under strict medical advice. Blood Pressure: May lower blood pressure—avoid combining with other strong antihypertensives unless prescribed. Nitrate Warning: Must not be used with nitrate medications (for chest pain/angina) due to risk of severe hypotension. Liver or Kidney Impairment: Dose adjustments may be needed. Alertness: Can cause dizziness—avoid driving or operating heavy machinery until you know your body’s response. Drug Interactions ALFUGEM T 5/10 may interact with other medicines: Nitrates (Nitroglycerin, Isosorbide): Can lead to life-threatening hypotension. Antihypertensives: May intensify blood pressure-lowering effects. Other PDE5 inhibitors (Sildenafil, Vardenafil): Should not be combined. Strong CYP3A4 inhibitors (e.g., Ketoconazole, Ritonavir): May increase Alfuzosin or Tadalafil levels. Alcohol: Increases dizziness and risk of low blood pressure. Conclusion ALFUGEM T 5/10 (Alfuzosin Hydrochloride ER & Tadalafil Tablets) is a comprehensive dual-action therapy designed for men experiencing both urinary issues due to BPH and sexual challenges related to ED. By combining an effective alpha-blocker with a proven PDE5 inhibitor, it provides relief from urinary discomfort while restoring erectile performance and confidence. With proper medical guidance, ALFUGEM T 5/10 can greatly improve overall quality of life, making it a reliable option for men seeking urological and sexual wellness in a single solution.
View Details
ALFUGEM T 5/10

INR385

TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise. With its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management. Key Ingredient Trelagliptin 100 mg A long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control. Key Benefits of TRELAQWK 100 Weekly dosing ensures greater convenience and adherence Reduces both fasting and postprandial blood sugar levels Supports natural blood sugar regulation without weight gain Low risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies Can be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas How TRELAQWK 100 Works TRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These incretin hormones: Stimulate insulin secretion in response to meals Reduce glucagon release, lowering blood sugar levels Thanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration. Directions for Use Dosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician Administration: May be taken with or without food, ideally on the same day each week Missed dose: Do not double the dose; consult your healthcare provider for guidance Possible Side Effects TRELAQWK 100 is usually well-tolerated, but some individuals may experience: Mild headache Nasopharyngitis (common cold-like symptoms) Constipation Upper respiratory tract infections Rare skin allergies (rash, itching) 👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.
View Details
TRELAQWK 100

INR550

TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle. Manufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management. Key Ingredient Trelagliptin (50 mg): A unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels. Key Benefits of TRELAQWK 50 Provides consistent blood sugar management with just one tablet per week Enhances insulin secretion while lowering glucagon levels in a glucose-dependent manner Helps reduce both fasting and postprandial blood glucose Convenient choice for patients with busy schedules who struggle with daily tablets Low risk of hypoglycemia when used as monotherapy Supports long-term improvement in HbA1c levels Mechanism of Action – How TRELAQWK 50 Works TRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin: Stimulates insulin secretion from the pancreas Reduces glucagon release from alpha cells Helps lower blood sugar, particularly after meals This mechanism provides both effective glycemic control and improved patient compliance. Directions for Use Take one tablet of TRELAQWK 50 once a week, on the same day each week Can be taken with or without food Swallow whole with a glass of water Follow your doctor’s advice for dosage adjustment Do not double the dose if missed; consult your healthcare provider Possible Side Effects TRELAQWK 50 is usually well-tolerated. However, some patients may experience: Mild headache Nasopharyngitis (cold-like symptoms) Diarrhea Stomach discomfort or indigestion Rare allergic reactions (rash, itching) If any unusual or persistent side effects occur, seek medical advice promptly.
View Details
TRELAQWK 50

INR375

Have any question or need any business consultation?

Contact Us

Have any question or need any business consultation?

Contact Us
Chat with us